Marie‐Bernadette Aretin

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

Farsad Eskandary, Heinz Regele, Lukas Baumann et al. · Journal of the American Society of Nephrology · 2017 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann et al. · Blood · 2020 · 226 citations · Full text

Medicine, Immunology, Oncology +16

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe et al. · Blood · 2017 · 72 citations

Medicine, Hematology, Oncology +13

Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases

Rupert Bartsch, Anna S. Berghoff, Julia Furtner et al. · Neuro-Oncology · 2024 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I)

Elisabeth Simader, Denise Traxler, Mohammad Mahdi Kasiri et al. · Scientific Reports · 2017 · 32 citations · Full text

Medicine, Dermatology, Pharmacology +17